KU Hematology & Medical Oncology Review 2019

 

KU Hematology & Medical Oncology Review 2019
R

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal Cell Carcinoma

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
178 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison
Genitourinary
11:59

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic …

KU Hematology & Medical Oncology Review 2019

R. Parikh

847 views
11:41

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal…

KU Hematology & Medical Oncology Review 2019

R. Parikh

178 views